baber/WOPTO huggingface dataset:
Patent NZ-244735-A (NZ)
Title: Pharmaceutical compositions containing a lipophilic oligosaccharide antibiotic salt
Inventor: PATEL MAHESH
IPC: A61K31/00
Filed: 1992-10-14
Abstract: Pharmaceutically acceptable compositions of matter comprising a lipophilic oligosaccharide antibiotic, e.g., the everninomicin-type antibiotic of Formula III, at least a stoichiometric amount of a base, e.g., NMG, an amount of, e.g., hydroxypropyl-b-cyclodextrin, and optionally a pharmaceutically acceptable non-ionic surfactant, e.g., Tween-80, pharmaceutical compositions containing such compositions of matter, methods of treating and preventing susceptible bacterial infections in animals especially human beings as well as a method of preventing adverse reaction syndrome while simultaneously delivering an antiinfective amount of a lipophilic oligosaccharide antibiotic such as that of Formula III to said animals as well as the use of the compositions of matter for the preparation of a medicament for such treating or preventing are disclosed. <CHEM>
Patent NZ-256808-A (NZ)
Title: Self-locking box
Inventor: FRIAR C EDWARD
IPC: B65D5/66
Filed: 1993-10-01
Abstract: A box for containing goods during storing, delivering, mailing, or shipping. The box has at least one end panel secured to a body panel by a locking tab and slot assembly so that the end panel cannot be unsecured without providing visible evidence of tampering. The leading edge of the locking tab has at least a partially tapered profile when the tab is folded for insertion through the slot. The slot may be curved to provide additional abutment between the associated locking tab and slot assembly. The container may have decorative motifs printed on the exterior surface to resemble a gift-wrapped box or a box having a unique or characteristic graphic design.
Patent NZ-280661-A (NZ)
Title: 1,2-bridged 1,4-dihydropyridines and medicaments containing them
Inventor: URBAHNS KLAUS
IPC: C07D471/04
Filed: 1995-12-13
Abstract: Tricyclic 1,4-dihydropyridine derivatives of formula (I) are new. R1 = 6-10C aryl substituted by 0-5 of NO2, CN, halo, CF3 and 1-6C alkylthio; R2 = 1-8C alkyl, 1-8C alkoxy or phenyl; a = 1-3; and R3+R4 = CH2CH2CH2 or CH2CH(Me)CH2.
Patent NZ-330831-A (NZ)
Title: Rechargable mobile phone battery with integral mains charger
Inventor: SHIH HUNG-MING
IPC: H02J7/02
Filed: 1998-06-30
Abstract: An AC/DC rechargeable mobile phone battery includes plug contacts 34, 35 that can be plugged into a mains outlet.  The plug contacts are attached to a mounting 31 that pivots on pivots 32, 33.  This allows the plug contacts to be retracted by rotating the contacts downwards.  When the contacts are extended as shown, terminals on the rear face of the mounting 31 contact terminals 51, 52 which connect with a charging circuit 50.  When the plug contacts 34, 35 are retracted, the plug terminals are out of contact with terminals 51, 52.
Patent NZ-334928-A (NZ)
Title: The production of knitted garments comprising a body section and legs, in a single production stage and in a single piece
Inventor: CONTI PAOLO
IPC: A41B11/14
Filed: 1997-10-30
Abstract: PCT No. PCT/IT97/00269 Sec. 371 Date Mar. 29, 1999 Sec. 102(e) Date Mar. 29, 1999 PCT Filed Oct. 30, 1997 PCT Pub. No. WO98/20192 PCT Pub. Date May 14, 1998The machine comprises in combination: two side units (1, 3) each having its own fabric forming cylinder (1C, 3C) with a plurality of needles and needle operating elements (1F, 3F, A1-A8), the cylinders being parallel with each other and close together and, in an intermediate position between said two cylinders (1C, 3C), two rectilinear beds (11A, 11B) next to each other, each with its own needles and elements (17A, 17B, A9, A17) for operating the needles of said beds.
Patent NZ-336002-A (NZ)
Title: Sulfonylurea and glitazone synergistic combinations for treatment of non-insulin dependent diabetes mellitus
Inventor: WHITCOMB RANDALL W
IPC: A61K31/4439
Filed: 1997-12-01
Abstract: Combinations comprising 3-250 mg of a sulfonylurea antidiabetic agent and from 100-1000 mg of a glitazone antidiabetic agent are disclosed.  The amounts disclosed are a synergistic combination useful for the treatment of non-insulin dependent diabetes mellitus and improving glycaemic control. The sulfonylurea is selected from glisoxepid, glyburide, acetohexamide, chlorpropamide, glibornuride, tolbutamide, tolazamide, glipizide, gliclazide, gliquidone, glyhexamide, phenbutamide, and tolcyclamide and the glitazone is selected from troglitazone, ciglitazone, pioglitazone, englitazone, TA 174, and BRL 49653.
Patent NZ-500639-A (NZ)
Title: Process for preparing and purifying 6-O-monoesters of castanospermine ([1S-(-alpha, 6-beta, 7-alpha, 8-beta, 8-alphabeta)]-octahydro-1,6,7,8-indolizinetetrol
Inventor: GORALSKI CHRISTIAN T
IPC: A61P35/04
Filed: 1998-04-27
Abstract: A process for preparing a compound of formula (I) where R is C1-C10 alkyl, phenyl or substituted phenyl and Y is hydrogen bromic acid, hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid, formic acid, acetic acid, propionic acid, succinic acid, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, ascorbic acid, a-ketoglutaric acid, glutamic acid, aspartic acid, maleic acid, hydroxymaleic acid, pyruvic acid, phenylacetic acid, benzoic acid, p-aminobenzoic acid, anthraniilic acid, p-hydroxybenzoic acid, salicyclic acid, hydroxyethanesulfonic acid, ethylenesulfonic acid, halobenzenesulfonic acid, toluenesulfonic acid, naphthalenesulfonic acid, methanesulfonic acid and sulfanilic acid, comprising; i) Treating a compound of formula (II) with bis(tributyltin) oxide in an organic solvent selected from the group consisting of o-xylene, m-xylene, p-xylene and mixed Xylenes and subsequently treating the reaction mixture with a compound of the formula (III), wherein X is halogen and R is defined as above; and ii) Subsequently treating the reaction mixture with a suitable organic solvent and an acid of formula Y defined above. Also described is a process for purifying a compound of formula (I), comprising: i) Combining above said compound with about a 95/5 v/v solution of ethanol and water to provide about a 13% by weight solution of said compound; ii) Heating the solution at reflux with agitation; iii) Cooling the solution to about 54oC; iv) Seeding the solution with said compound to produce a crystal slurry; v) Heating the crystal slurry at about 64oC until the crystal slurry is reduced by 70% to 80%; vi) Maintaining the temperature of the crystal slurry at about 64oC for about 2 hours; vii) Initiating a suitable cooling profile to provide a final temperature of the crystal slurry of less than about 0oC; viii) Collecting the purified compound.
Patent NZ-504881-A (NZ)
Title: Building elements with a U-shaped cavity and within the cavity, the tongue extends beyond at least one of the side walls of the cavity
Inventor: ALLEN ROBERT ANDREW
IPC: E06B1/32
Filed: 1998-10-21
Abstract: An elongate joining or edging element (9) for securing to  a  member  (7,  8)  formed from an  at  least  partially resiliently deformable material such as timber. The  element includes  a  generally planar surface (13, 14),  from  which extends  a  substantially "U-shaped" cavity (11)  formed  by two  opposed  first side walls (18). The cavity  includes  a first  tongue  section (19, 20) extending  intermediate  and parallel  to the side walls. The side walls (18) and  tongue section  (19,  20)  are  configured to  frictionally  and/or physically   interact  by  means  of  a   press   fit   with corresponding substantially parallel slots (22) and/or  edge surfaces  (23)  formed  in  a  connecting  surface  of   the resilient  member  (7, 8) so as to secure  the  element  (9) thereto.
Patent NZ-508097-A (NZ)
Title: Cleaning of sheep prior to slaughter
Inventor: JONES WARREN LYALL
IPC: B65G15/06
Filed: 2000-11-13
Abstract: A wash station for cleaning animals (10) comprising a restraining/transporting conveyor (12) consisting of a pair of belts (13 and 14) in a truncated V shape.  The primary wash zone has a plurality of nozzles (20) placed equi-distance apart facing inwardly from a support frame (22) dispensing a cleaning or rinsing fluid.  A series of such stations can be used end to end for multiple wash and rinse cycles.
Patent NZ-508316-A (NZ)
Title: A treatment for neurogenic inflammation in a variety of pathological conditions involving the activation of non-myelinated nerve fibres
Inventor: MERCE-VIDAL RAMON
IPC: A61P25/00
Filed: 1999-01-13
Abstract: A derivative of aryl (or heteroaryl) azolylcarbinol of formula (I) useful in the manufacture of a medicament for the treatment of neurogenic inflammation in mammals where; Ar is a phenyl or thienyl radical, unsubstituted or substituted by 1, 2, or 3 identical or different substituents, selected from a group comprising fluorine, chlorine, bromine, methyl, trifluoromethyl and methoxy; R1 is a hydrogen or an alkyl group C1 - C4; R2 is a dialkyl (C1 - C4) aminoalkyl (C2 - C3), or azaheterocyclyl-alkyl (C2 - C3); and Het is a five membered azotic heterocyclic aromatic ring that contains from 1-3 nitrogen atoms, unsubstituted or optionally substituted by 1 or 2 substituents, identical or different, selected from the group comprising fluorine, chlorine, bromine, and methyl.
Patent NZ-509179-A (NZ)
Title: Method for reducing the amount of trisulphides in the production of recombinant peptides using an alkali metal or alkaline earth metal salt
Inventor: HEMMENDORFF BARBRO
IPC: C07K14/61
Filed: 1999-07-05
Abstract: A method of reducing the amount of trisulphides in the production of recombinant peptides comprises adding an alkali metal or alkaline earth metal salt during or after the fermentation step.
Patent NZ-509518-A (NZ)
Title: Arylsulfone linkers for mass spectrometric analysis
Inventor: SCHMIDT GUNTER
IPC: C12Q1/6872
Filed: 1999-07-13
Abstract: A phenyl derivative has the formula (I) wherein: R1 is an electron withdrawing substituent; X is a reporter group which comprises a mass marker detectable by a mass spectrometry and Each handle is independently a single bond directly attaching the X groups to the phenyl ring and the N atom respectively or a reactive group capable of attaching the X groups to the to the phenyl ring and the N atom respectively. The handle can be -CO-NH-, -NH-CO-NH-, -NH-CS-NH-, -CH2-NH-, -SO2-NH-, -NH-CH2-NH- or -OP(=O)(O)O-; A method of characterizing an analyte comprises: a) providing a compound of formula R-SOn-R' wherein:  R is the reporter group and R' is the analyte or R' is the reporter group and R is the analyte wherein the analyte is attached by a cleavable linker to a reporter group capable of identifying the analyte with the reporter group, which comprises a mass marker detectable by a mass spectrometry and n is 1 or 2; b) cleaving the reporter group from the analyte and c) identifying the reporter group thereby characterizing the analyte. R and/or R' can be a covalent linkage attaching the analyte to the cleavable linker such as CO-NH-, -NH-CO-NH-, -NH-CS-NH-, -CH2-NH-, -SO2-NH-, -NH-CH2-NH- or -OP(=O)(O)O-.
Patent NZ-519329-A (NZ)
Title: Yeast-based process for production of a carbinol (phenylacetylcarbinol) in the presence of a supercritical fluid or liquified gas
Inventor: TREWHELLA MAURICE ARTHUR
IPC: C12P7/26
Filed: 2000-12-13
Abstract: A method for the synthesis of a substituted or unsubstituted carbinol compound comprises the steps of subjecting the corresponding substituted or unsubstituted aromatic aldehyde to acyloin condensation mediated by yeast in the presence of either a supercritical fluid or a liquefied gas and then recovering the carbinol compound. Preferably the yeast is Saccharomyces cerevisiae, the liquefied gas is selected from carbon dioxide, methane, ethane, ethylene, propane, butane and liquefied petroleum gas and the supercritical fluid is selected from carbon dioxide, ethane, nitrous oxide, xenon, fluoroform, monofluoroform, sulphur hexafluoride and chlorotrifluoromethane.
Patent NZ-522690-A (NZ)
Title: Polymorph of ritonavir
Inventor: BAUER JOHN F
IPC: C07D277/28
Filed: 1999-07-19
Abstract: Substantially purely amorphous ritonovir. A process for its production is also disclosed.
Patent NZ-528816-A (NZ)
Title: Zinc-based hot-dip galvanized steel sheet excellent in retention of gloss
Inventor: KOMATSU ATSUSHI
IPC: C22C38/00
Filed: 2002-07-24
Abstract: A method of producing a hot-dip Zn plated steel sheet excellent in luster-retaining property is disclosed, which comprises: a step of continuously immersing and withdrawing steel strip into/from a hot-dip Zn base bath containing Al: 4.0 - 15 mass % and Mg: 1.0 - 4.0 mass %, thereby forming a plating layer thereon; and a step of thereafter continuously passing the steel strip through a water quenching zone that effects cooling while bringing the completely solidified plating layer surface into contact with a water stream, wherein degradation of the plating layer luster being inhibited at this time by controlling strip temperature on the water quenching zone entry side to lower than 105 DEG C. The employment of the method stabilizes the oxidation states of Al and Mg present in the surface portion of the plating layer by incorporating a small amount of a suitable readily oxidizing element such as Y, Zr or Si in the plating bath, which results in the suppression of deterioration in the surface gloss of a Zn-Al-Mg base hot dip steel sheet.
Patent NZ-529477-A (NZ)
Title: Total reflection optic element
Inventor: LADSTATTER GERALD
IPC: F21V5/00
Filed: 2002-05-17
Abstract: An optical element ( 1 ) for reflecting and/or redirecting light rays (L 1 ) entering therein and again emerging therefrom consists of a transparent base body ( 2 ) which is so structured and/or formed that, with the formation of reflection surfaces ( 8 ) bounding the base body ( 2 ), at least a part of the light rays (L 1 ) impinging upon the reflection surfaces ( 8 ) upon emergence from the transparent base body ( 2 ) are totally reflected, and at least one cover body ( 9 ) arranged behind the reflection surfaces ( 8 ). The reflection surfaces ( 8 ), and the surfaces of the cover body or bodies ( 9 ) towards the reflection surfaces, are adapted to one another such that between them there remains a thin gap ( 10 ) or only point contacts exist.
Patent NZ-532865-A (NZ)
Title: Non-sporulating bacillus subtilis having parts of the gene encoding sigma G deleted
Inventor: KOSKI PERTTI
IPC: C12N15/10
Filed: 2002-11-05
Abstract: A non-sporulating Bacillus subtilis strain where at least 150 nucleotides are deleted from its sigG gene is described. This deletion is disclosed to comprise at least part of either of the functional regions of the sigG gene which code the amino acids 67 to 80 or 229 to 248, respectively, of the sigG protein, having swiss PROT accession number P19940. A Bacillus subtilis strain is also described which contains Seq. ID No. 9, as well as a strain wherein upstream from the selection marker gene there is an at least 20-nucleotides long overlap region that is homologus with an at least 20-nucleotides long overlap region downstream from the selection marker gene. The use of the strain as a production organ to produce a recombinant polypeptide or beta-lactamase, and a method for preparing a biologically prepared product with the non-sporulating bacterium is also disclosed.
Patent NZ-533774-A (NZ)
Title: Preventatives/remedies for urinary disturbance
Inventor: ISHIHARA YUJI
IPC: A61K31/40
Filed: 2002-12-26
Abstract: Disclosed herein is a compound of formula (Ia) and the process of preparing said compound for the preparation of a preventive or therapeutic agent for voiding disturbance, wherein the voiding disturbance is accompanied with benign prostatic hyperplasia and is due to detrusor underactivity.
Patent NZ-535064-A (NZ)
Title: Water immiscible solvent for extraction of acetic acid
Inventor: GADDY JAMES L
IPC: C07C/
Filed: 1999-09-07
Abstract: Disclosed is a modified water-immiscible solvent useful in the extraction of acetic acid from aqueous streams, comprising about 91% by volume of a mixture of isomers of highly branched di-alkyl amines, about 0.2% by volume of mono-alkyl amines, and about 9% by volume of tri-alkyl amines, the solvent having a coefficient of distribution of greater than 10. Also disclosed is a method for preparing a modified solvent comprising the steps of; (a) distilling from an unmodified solvent comprising mono-alkyl amines, highly branched di-alkyl amines and tri-alkyl amines, about 9% of di-alkyl amines, about 99% of mono-alkyl amines, and about 90% by volume tri-alkyl amines in the unmodified solvent, thereby improving the acetic acid capacity of the distilled solvent, wherein the distillation of the mono-alkly amines, di-alkyl amines and tri-alkyl amines occurs at from 100-160°C at about 70 torr, and (b) washing the distilled solvent using an organic acid at an acid to solvent ratio of about 1:1 to about 5:1. Also disclosed is a process for obtaining acetic acid from an aqueous phase. (62) Divided out of 526442
Patent NZ-535931-A (NZ)
Title: A dish-washing machine with versatility of position
Inventor: PARDINI GIANLUCA
IPC: A47L15/42
Filed: 2004-10-14
Abstract: Disclosed is a dishùwashing machine (1) comprised of at least one supporting structure (2); a washing station (4), defined by one or more washing arms (5); a rinsing station (6), defined by one or more rinsing arms (7); and movement means (3), designed to displace a dish rack (10) at least from the washing station (4) to the rinsing station (6). The dishù washing machine being characterized in that it comprises of at least two attachment assemblies (8, 9) for attachment of the rinsing arms (7) positioned on opposite sides of the washing arms (5), and in that the movement means (3) are reversible.
Patent NZ-538711-A (NZ)
Title: Antigen/antibody/antigen sandwich assays for detecting hepatitis C virus infections
Inventor: ARCANGEL PHILLIP
IPC: C12Q1/70
Filed: 2003-09-08
Abstract: An HCV antigen/antibody/antigen assay is provided. The assay employs an isolated first antigen from a region of the HCV polyprotein, and an HCV multiple epitope fusion antigen that includes an epitope from the same region of the polyprotein as the first antigen. Both the first antigen and the multiple epitope fusion antigen bind antibodies present in an HCV-infected sample.
Patent NZ-539164-A (NZ)
Title: Pyrazolopyrimidines as cyclin dependent kinase inhibitors
Inventor: GUZI TIMOTHY J
IPC: A61P35/00
Filed: 2003-09-03
Abstract: A novel class of pyrazolo[1,5-a]pyrimidine compounds are described to be represented by the structural formula III. Q is ûS(O2)- or ûC(O)-; R is aryl or heteroaryl; and the possible sustitutents of R2, R3, R4 are disclosed. Also disclosed are methods of inhibiting cyclin dependent kinases (CDK), and treating diseases associated with cyclin dependant kinase such as cancer, leukaemia and lymphoma. The methods involve the administration of a therapeutically effective amount of at least one compound of formula III to a non-human animal
Patent NZ-541759-A (NZ)
Title: Phenylacetamides and their use as glucokinase modulators
Inventor: FYFE MATTHEW COLIN THOR
IPC: A61P3/10
Filed: 2004-02-10
Abstract: Disclosed are tri(cyclo) amide compounds substituted i) at the carbonyl carbon with an ethyl/ethenyl attached to a phenyl ring and an aryl/heteroaryl/heterocyclic ring, and ii) at the amino with a nitrogen bearing heteroaryl ring, which are modulators of glucokinase and are useful in the prophylactic or therapeutic treatment of hyperglycemia and type II diabetes.
Patent NZ-542071-A (NZ)
Title: Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
Inventor: TJOA BENJAMIN A
IPC: C12N5/00
Filed: 2004-02-27
Abstract: Disclosed is a method for differentiating monocytic dendritic cell precursor into immature dendritic cells, comprising: a) providing a cell population comprising non-activated monocytic dendritic cell precursors; b) contacting the non-activated dendritic cell precursors in a culture vessel with a dendritic cell culture media supplemented with granulocyte-macrophage colony stimulating factor in the absence of additional cytokines.
Patent NZ-543432-A (NZ)
Title: Scaffolding bracket using gripping member on pivotal linkage to grip building frame member
Inventor: CURTIN JAMES LAURENCE
IPC: E04G21/32
Filed: 2004-06-29
Abstract: There is a bracket for use in building construction. The bracket has a support leg (7) with an attachment point (12) for, fixing onto a building frame component (11). The attachment point includes a gripping member (17) mounted on a pivotal linkage (14) extending from the support leg (7). In use of the bracket to carry a working load B the leg and. gripping member can be located against opposite faces of the building frame component so that the working load generates a clamping force on the component between the gripping member (17) and support leg (7) which resists movement of the bracket.
Patent NZ-544726-A (NZ)
Title: Infant or follow-on formula
Inventor: SECRETIN MARIE-CHRISTINE
IPC: A23L33/00
Filed: 2004-06-18
Abstract: Provided is an infant or follow-on formula comprising a source of proteins, a source of lipids, a source of carbohydrates and a probiotic, wherein the source of lipids included arachidonic acid (ARA) and docosahexanoic acid (DHA) and the DHA content is between 0.2 and 0.5% of total fatty acids in the lipid source. Further provided are similar compositions with specified ARA/DHA ratios and probiotics as well as the use of the compositions for the manufacture of a composition for strengthening natural immune defences in infants.
Patent NZ-551666-A (NZ)
Title: Combinations comprising antimuscarinic agents and beta-adrenergic agonists
Inventor: GRAS ESCARDO JORDI
IPC: A61K31/439
Filed: 2005-05-31
Abstract: Disclosed is a combination comprising the M3 muscarinic receptor antagonist (3R)-1-phenethyl-3-(9H-xanthene-9carbonyloxy)-1-azoniabicyclo[2.2.2]octane, in the form of a salt with a pharmaceutically acceptable anion or a mono or polyvalent acid, and a â2 agonist. Also disclosed is the use of the above combination for treating a respiratory disease which responds to M3 antagonism, such as asthma or chronic obstructive pulmonary disease.
Patent NZ-555368-A (NZ)
Title: Cream cheese product and its method of preparation
Inventor: WOLFSCHOON-POMPO ALAN
IPC: A23C21/06
Filed: 2005-11-21
Abstract: Provided is a cream cheese product prepared by a process comprising the steps of: (a) acidifying a whey protein concentrate with a food grade acidulant or with starter bacteria to reduce the pH to 4.5 to 5.2, (b) slowly heating the acidified whey protein concentrate of step (a) within a period of 15 to 120 min to a temperature of 75° to 90°C and maintaining it for at least 30 min to produce a functional whey protein concentrate, (c) optionally blending the whey protein concentrate of step (b) with milk fat in a weight ratio of 60:40 to 100:0 wherein step (c) may be carried out before step (b), (d) homogenizing the blend obtained in step (b) or (c) in a 2-stage high-pressure homogenizer at pressures of 300 to 400 bar in its first stage and 50 to SO bar in its second stage and a temperature of 5° to 75°C to produce an emulsified functional whey protein concentrate, (e) blending the emulsified functional whey protein concentrate of step (d) with curd, the fat content of which is adjusted in accordance with the milk fat portion added in step (c) and with the desired fat content of the cream cheese product, and adding salt and optional stabilizers, and (f) homogenizing the blend of step (e) in a second 2-stage high-pressure homogenizer at pressures of 300 to 400 bar in its first stage and 50 to SO bar in its second stage and at a temperature of 68°C to 90°C to form the cream cheese product.
Patent NZ-561693-A (NZ)
Title: Vehicle body with slide out having plural sanitary fixtures displaceable with the slide out
Inventor: MACLEAN COLIN ROBERT
Filed: 2007-09-19
Abstract: Disclosed is a vehicle body with a slide out having plural sanitary fixtures displaceable with the slide out.